Clobex 0.05% Lotion 59ml

Manufacturer GALDERMA Active Ingredient Clobetasol Lotion(kloe BAY ta sol) Pronunciation kloe BAY ta sol
It is used to treat skin rashes and other skin irritation.It is used to treat plaque psoriasis.
đŸˇī¸
Drug Class
Topical Corticosteroid
đŸ§Ŧ
Pharmacologic Class
Glucocorticoid Receptor Agonist; Anti-inflammatory Agent
🤰
Pregnancy Category
Category C
✅
FDA Approved
May 2004
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Clobex Lotion contains a strong medicine called a corticosteroid. It helps reduce redness, swelling, and itching caused by skin conditions like psoriasis. It's important to use it exactly as prescribed, usually once a day for a short time, because it's very potent.
📋

How to Use This Medicine

Proper Use of This Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. It is essential to use this medication as directed, even if your symptoms improve.

Application Instructions

Apply this medication only to your skin, avoiding ingestion or contact with your mouth, nose, and eyes, as it may cause burning.
Wash your hands before and after application, unless your hand is the treated area, in which case you should not wash it after use.
Clean the affected area before application and dry it thoroughly.
Apply a thin layer of the medication to the affected skin and gently rub it in.
Avoid applying this medication to your face, underarms, or groin area unless your doctor instructs you to do so.
Do not cover the treated area with bandages, dressings, or makeup unless your doctor advises you to do so.

Storage and Disposal

Store this medication at room temperature, avoiding refrigeration or freezing.
Be aware of the medication's expiration date or the length of time you can store it before disposal.
Keep all medications in a safe location, out of the reach of children and pets.

Missed Dose

If you miss a dose, apply it as soon as you remember.
If it is close to the time for your next dose, skip the missed dose and resume your regular application schedule.
Do not apply two doses at the same time or use extra doses to make up for a missed dose.
💡

Lifestyle & Tips

  • Apply a thin layer to the affected skin area only, once daily.
  • Do not use for more than 2 consecutive weeks unless directed by your doctor.
  • Do not use more than 50 grams (one 59 mL bottle) per week.
  • Do not use on the face, groin, or armpits unless specifically instructed by your doctor.
  • Avoid using occlusive dressings (e.g., bandages, plastic wrap) over the treated area unless directed by your doctor, as this can increase absorption.
  • Wash hands thoroughly after applying the lotion, unless hands are the treated area.
  • Avoid contact with eyes.
  • Do not use for diaper rash.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Apply a thin layer to affected skin areas once daily. Treatment should be limited to 2 consecutive weeks.

Condition-Specific Dosing:

maximum_weekly_dose: Do not exceed 50 g (59 mL bottle) per week.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not recommended for patients under 12 years of age due to increased risk of systemic absorption and HPA axis suppression.
Adolescent: For patients 12 years and older, use with extreme caution and for the shortest possible duration, similar to adult dosing but with increased monitoring for systemic effects.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment needed for topical use.
Moderate: No specific dose adjustment needed for topical use.
Severe: No specific dose adjustment needed for topical use.
Dialysis: No specific considerations for topical use, as systemic absorption is minimal under normal conditions.

Hepatic Impairment:

Mild: No specific dose adjustment needed for topical use.
Moderate: No specific dose adjustment needed for topical use.
Severe: No specific dose adjustment needed for topical use.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Clobetasol propionate is a high-potency corticosteroid. It induces phospholipase A2 inhibitory proteins, collectively called lipocortins. These proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Thus, clobetasol exerts anti-inflammatory, antipruritic, and vasoconstrictive actions.
📊

Pharmacokinetics

Absorption:

Bioavailability: Variable; systemic absorption depends on the vehicle, integrity of the epidermal barrier, duration of exposure, and use of occlusive dressings. Generally low but can increase significantly with extensive use or damaged skin.
Tmax: Not typically quantified for topical application leading to systemic effects.
FoodEffect: Not applicable for topical administration.

Distribution:

Vd: Not well-quantified for topical application leading to systemic effects.
ProteinBinding: Approximately 90% (for systemically absorbed corticosteroids).
CnssPenetration: Limited with typical topical use; may occur with significant systemic absorption.

Elimination:

HalfLife: Not well-defined for topical application leading to systemic effects; systemic corticosteroids have varying half-lives (e.g., 4-6 hours for cortisol).
Clearance: Not well-quantified for topical application leading to systemic effects.
ExcretionRoute: Primarily renal excretion of metabolites.
Unchanged: Minimal unchanged drug excreted.
âąī¸

Pharmacodynamics

OnsetOfAction: Anti-inflammatory effects typically observed within hours to days.
PeakEffect: Peak therapeutic effect usually within 1-2 weeks of consistent application.
DurationOfAction: Effects persist as long as applied; residual effects may last for days after discontinuation.
Confidence: Medium

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion
+ Feeling sleepy
+ Unusual thirst or hunger
+ Passing urine more often
+ Flushing
+ Fast breathing
+ Breath that smells like fruit
Signs of Cushing's syndrome, such as:
+ Weight gain in the upper back or belly
+ Moon face
+ Severe headache
+ Slow healing
Signs of a weak adrenal gland, including:
+ Severe upset stomach or vomiting
+ Severe dizziness or passing out
+ Muscle weakness
+ Feeling very tired
+ Mood changes
+ Decreased appetite
+ Weight loss
Skin changes, such as:
+ Pimples
+ Stretch marks
+ Slow healing
+ Hair growth
Irritation where the medication was applied
Thinning of the skin
Changes in eyesight, eye pain, or severe eye irritation

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only have minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:

Burning or stinging
Dry skin
* Redness

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Increased redness, swelling, or pus (signs of infection)
  • Severe burning, itching, or irritation at the application site
  • Skin thinning, easy bruising, or stretch marks (striae)
  • Changes in skin color (lightening)
  • Acne-like breakouts
  • Unusual fatigue or weakness
  • Weight gain, especially in the face or trunk
  • High blood sugar (increased thirst, urination)
  • Blurred vision or other eye problems (e.g., cataracts, glaucoma) with prolonged use
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction and its symptoms.
If you have thinning skin at the site where you will be applying this medication.
* If there is an active infection at the site where this medication will be used.

This list is not exhaustive, and it is crucial to discuss all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, with your doctor and pharmacist. Additionally, share any existing health problems to ensure safe use.

To guarantee your safety, always consult your doctor before starting, stopping, or adjusting the dose of any medication, including this one.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

This medication is not intended to treat diaper rash, acne, rosacea, or rashes around the mouth. When applying it to a large area of skin or near open wounds, exercise caution and consult your doctor.

Before using any other skin products or medications, including soaps, discuss them with your doctor to ensure safe use. Avoid applying this medication to cuts, scrapes, or damaged skin. Do not use this medication for an extended period beyond what your doctor has prescribed.

If this medication is accidentally swallowed, seek immediate medical attention by calling a doctor or poison control center. Prolonged use of this medication may increase the risk of developing cataracts or glaucoma; therefore, consult your doctor about this potential risk.

This medication may not be suitable for children of all ages, so it is crucial to consult your doctor before administering it to a child. When using this medication in children, exercise caution, as they may be at a higher risk of experiencing certain side effects. In some cases, this medication may affect growth in children and teenagers, necessitating regular growth checks; consult your doctor about this potential risk.

If you are breastfeeding, avoid applying this medication directly to the nipple or the surrounding area. If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor to discuss the potential benefits and risks to you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Symptoms of Cushing's syndrome (e.g., moon face, central obesity, buffalo hump, hypertension, hyperglycemia)
  • Adrenal insufficiency (fatigue, weakness, nausea, vomiting, hypotension) upon abrupt withdrawal after prolonged, extensive use

What to Do:

Topical overdose is rare but can occur with prolonged or extensive use, leading to systemic effects. Treatment is symptomatic and supportive. Gradual withdrawal of the corticosteroid may be necessary if HPA axis suppression occurs. Call a poison control center immediately (1-800-222-1222) or seek emergency medical attention.

Drug Interactions

Monitoring

đŸ”Ŧ

Baseline Monitoring

Skin condition and extent of disease (e.g., psoriasis, eczema)

Rationale: To establish a baseline for assessing treatment efficacy and adverse effects.

Timing: Prior to initiation of therapy.

📊

Routine Monitoring

Clinical response (reduction in inflammation, pruritus, erythema)

Frequency: Weekly or as clinically indicated during treatment period.

Target: Improvement in symptoms.

Action Threshold: Lack of improvement or worsening symptoms may indicate need for re-evaluation or alternative therapy.

Local skin adverse reactions (e.g., atrophy, striae, telangiectasias, burning, itching, folliculitis, infections)

Frequency: Weekly or as clinically indicated.

Target: Absence or minimal adverse effects.

Action Threshold: Presence of significant or worsening local adverse effects warrants discontinuation or reduction in frequency/potency.

Signs of HPA axis suppression (e.g., fatigue, weakness, nausea, vomiting, hypotension, weight loss)

Frequency: Periodically, especially with extensive use, prolonged use, or in pediatric patients.

Target: Absence of symptoms.

Action Threshold: If suspected, perform HPA axis evaluation (e.g., ACTH stimulation test, morning plasma cortisol). Discontinue or gradually withdraw if suppression is confirmed.

đŸ‘ī¸

Symptom Monitoring

  • Burning or stinging at application site
  • Itching
  • Skin atrophy (thinning, shiny skin)
  • Striae (stretch marks)
  • Telangiectasias (spider veins)
  • Folliculitis
  • Acneiform eruptions
  • Hypopigmentation
  • Perioral dermatitis
  • Allergic contact dermatitis
  • Secondary infection
  • Symptoms of Cushing's syndrome (e.g., moon face, central obesity, buffalo hump, hypertension, hyperglycemia)
  • Symptoms of adrenal insufficiency (e.g., fatigue, weakness, nausea, vomiting, hypotension, weight loss) upon withdrawal

Special Patient Groups

🤰

Pregnancy

Clobetasol is Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. High-potency topical corticosteroids should generally be avoided or used with extreme caution during pregnancy.

Trimester-Specific Risks:

First Trimester: Potential for teratogenicity, though data are limited for topical use. Systemic absorption is generally low.
Second Trimester: Risk of systemic effects on the fetus (e.g., growth retardation, adrenal suppression) if significant maternal absorption occurs.
Third Trimester: Risk of systemic effects on the fetus, including HPA axis suppression, if significant maternal absorption occurs. Neonates born to mothers who received substantial doses of corticosteroids during pregnancy should be carefully observed for signs of hypoadrenalism.
🤱

Lactation

It is not known whether topical administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in breast milk. Systemically administered corticosteroids appear in human milk and could suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects. Caution should be exercised when Clobex Lotion is administered to a nursing woman. Avoid applying to the breast area to prevent infant ingestion.

Infant Risk: Low risk with limited, short-term use on small areas. Higher risk with extensive, prolonged use, or application to areas where the infant could ingest the drug (e.g., breast).
đŸ‘ļ

Pediatric Use

Not recommended for children under 12 years of age. Pediatric patients may be more susceptible to systemic toxicity from topical corticosteroids due to their larger skin surface area to body weight ratio. HPA axis suppression, Cushing's syndrome, and intracranial hypertension have been reported in children receiving topical corticosteroids. Chronic corticosteroid therapy may interfere with growth and development in children.

👴

Geriatric Use

Clinical studies of Clobex Lotion did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. Elderly patients may have thinner skin, which could increase systemic absorption.

Clinical Information

💎

Clinical Pearls

  • Clobetasol propionate 0.05% is a super high-potency topical corticosteroid. Use it sparingly and for short durations (typically no more than 2 consecutive weeks) to minimize the risk of local and systemic side effects.
  • The 59 mL bottle of Clobex Lotion contains 50 grams of clobetasol propionate. Patients should be instructed not to use more than one bottle per week.
  • Avoid use on the face, groin, or axillae due to increased risk of skin atrophy, striae, and telangiectasias in these sensitive areas.
  • Educate patients on the signs of HPA axis suppression (e.g., fatigue, weakness) and local skin adverse effects (e.g., thinning, bruising).
  • Consider alternative therapies or lower potency corticosteroids for maintenance therapy once acute flares are controlled.
  • Risk of HPA axis suppression is higher in pediatric patients, those using occlusive dressings, or those applying to large body surface areas.
🔄

Alternative Therapies

  • Other topical corticosteroids (e.g., fluocinonide, triamcinolone, betamethasone, hydrocortisone) of varying potencies.
  • Topical calcineurin inhibitors (e.g., tacrolimus, pimecrolimus) for sensitive areas or long-term use.
  • Vitamin D analogs (e.g., calcipotriene) for psoriasis.
  • Systemic therapies (e.g., biologics, oral retinoids, methotrexate, cyclosporine) for severe or extensive disease.
💰

Cost & Coverage

Average Cost: $100 - $300+ per 59mL bottle
Generic Available: Yes
Insurance Coverage: Tier 2 or 3 (Brand), Tier 1 (Generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide information about the medication taken, the amount, and the time it happened.